Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (311-320 of 330) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|November 18, 2021
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohortsPernille Lassen, Shao Hui Huang, Jie Su, et al.
Acta Oncologica (Stockholm, Sweden)|September 13, 2023
Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patientsCamilla Panduro Nielsen, Ebbe Laugaard Lorenzen, Kenneth Jensen, et al.
Cell Chemical Biology|August 21, 2018
APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer CellsKristian Mark Jacobsen, Nikolaj Lilholm Villadsen, Thomas Tørring, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2021
Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1Lone E Forner, François J Dieleman, Richard J Shaw, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
The Cochrane Database of Systematic Reviews|December 15, 2010
Hyperfractionated or accelerated radiotherapy for head and neck cancerBertrand Baujat, Jean Bourhis, Pierre Blanchard, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2003
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer researchJulio E Celis, Pavel Gromov, Irina Gromova, et al.
Clinical and Translational Radiation Oncology|June 15, 2026
Radiotherapy quality assurance in the Danish breast cancer Group RT Natural trialKristine Wiborg Høgsbjerg, Mette Skovhus Thomsen, Kristian Boye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROGAnnett Linge, Steffen Löck, Volker Gudziol, et al.
Pageof 33

Showing results (311-320 of 330) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|November 18, 2021
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohortsPernille Lassen, Shao Hui Huang, Jie Su, et al.
Acta Oncologica (Stockholm, Sweden)|September 13, 2023
Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patientsCamilla Panduro Nielsen, Ebbe Laugaard Lorenzen, Kenneth Jensen, et al.
Cell Chemical Biology|August 21, 2018
APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer CellsKristian Mark Jacobsen, Nikolaj Lilholm Villadsen, Thomas Tørring, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2021
Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1Lone E Forner, François J Dieleman, Richard J Shaw, et al.
Clinical Proteomics|June 22, 2011
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T Hennessy, Yiling Lu, Ana Maria Gonzalez-Angulo, et al.
Clinical Proteomics|September 13, 2011
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancerAna M Gonzalez-Angulo, Bryan T Hennessy, Funda Meric-Bernstam, et al.
The Cochrane Database of Systematic Reviews|December 15, 2010
Hyperfractionated or accelerated radiotherapy for head and neck cancerBertrand Baujat, Jean Bourhis, Pierre Blanchard, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2003
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer researchJulio E Celis, Pavel Gromov, Irina Gromova, et al.
Clinical and Translational Radiation Oncology|June 15, 2026
Radiotherapy quality assurance in the Danish breast cancer Group RT Natural trialKristine Wiborg Høgsbjerg, Mette Skovhus Thomsen, Kristian Boye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROGAnnett Linge, Steffen Löck, Volker Gudziol, et al.
Pageof 33